Liver Diseases  >>  ledipasvir/sofosbuvir  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ledipasvir/sofosbuvir / Generic mfg.
NCT02339038: Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia

Completed
4
600
US
Ledipasvir 90 mg and Sofosbuvir 400 mg, Harvoni
National Institutes of Health Clinical Center (CC)
HCV HIV
06/16
07/18

Download Options